The Efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac Vaccines in Patients with Cancer. Simsek M, Yasin AI, Besiroglu M, Topcu A, et al. J Med Virol 2022 May 5. doi: 10.1002/jmv.27835.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Simsek M, Yasin AI, Besiroglu M, Topcu A, et al. The Efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac Vaccines in Patients with Cancer. J Med Virol 2022 May 5. doi: 10.1002/jmv.27835.
PMID: 35513241